Michael Haller

Read our 2023 Year in Review to see our accomplishments over the past year as a global leader in diabetes research, patient care, and education.

UF Pediatric Endocrinology team ranked top 10 nationally   Please join us in congratulating the UF Pediatric Endocrinology team for their recognition as the highest-ranked specialty at UF Health Shands Children’s Hospital and as a top 10 nationally ranked program by U.S. News & World Report!  To read…

University of Florida and Stanford University researchers have identified areas in Florida and California where people with Type 1 diabetes may have difficulty getting the care and support they need to manage their disease. .

UFDI Investigator Michael Haller, M.D. and collaborators found that among overweight adolescents with type 1 diabetes, the addition of metformin to insulin did not improve glycemic control after 6 months.

UFDI Investigator Michael Haller, M.D. and other researchers found that intranasal glucagon was highly effective in treating insulin-induced hypoglycemia in adults with type 1 diabetes.

UFDI Investigator Michael Haller, M.D. and other researchers found that among overweight adolescents with type 1 diabetes, the addition of metformin to insulin did not improve glycemic control after 6 months.

UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing agents in subjects with T1D, but only when combined with immunodepleting agents where synergistic mechanisms of action have previously demonstrated…

Dr. Haller currently serves as the Principal Investigator for the TrialNet ATG/GCSF study funded collaboratively by the NIH, the Helmsley Trust, and Sanofi.

Giovanna Beauchamp, M.D. and Michael J. Haller, M.D., M.S. recently released a review of several type 1 diabetes (T1D) prevention studies in Current Diabetes Reports. The publication, titled ‘Can We Prevent Type 1 Diabetes?,’ highlights recent and ongoing efforts to understand the…

Several studies have documented reduced incidence of diabetic ketoacidosis (DKA) in new-onset T1D when high-risk children are identified at an early age. As a result, researchers have questioned whether T1D screening for the purpose of preventing DKA is a feasible option. UF researchers worked with Abt Associates to perform a…